Spots Global Cancer Trial Database for cervical intraepithelial neoplasia
Every month we try and update this database with for cervical intraepithelial neoplasia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV | NCT05266898 | Papillomavirus ... Human Immunodef... Papillomavirus ... Serology Cervical Intrae... Anal Intraepith... Oral Cavity Inf... | Human papilloma... | 18 Years - 45 Years | Louisiana State University Health Sciences Center in New Orleans | |
| Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia | NCT00513123 | Cervical Cancer | Colposcopy | 18 Years - | M.D. Anderson Cancer Center | |
| Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine | NCT01356823 | Cervical Intrae... Cervical Cancer | 30μg HPV 60μg HPV 90μg HPV Hepatitis B vac... | 18 Years - 25 Years | Xiamen University | |
| Conservative Management of HSIL in Patients With Future Pregnancy Aspiration | NCT04783805 | Cervical Intrae... Squamous Intrae... Uterine Cervica... | Conservative ma... Conization | - | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |
| Meta-analysis of Efficacy of Topotecan | NCT01160185 | Cervical Intrae... | paclitaxel cisplatin topotecan | 21 Years - | GlaxoSmithKline | |
| A Study of ABI-2280 Vaginal Tablet in Participants With Cervical Intraepithelial Neoplasia | NCT05502367 | Cervical Intrae... | ABI-2280 | 25 Years - 55 Years | Antiva Biosciences | |
| Comparison of Human Papillomavirus Integrated DNA and Messenger RNA in Cervical Neoplasia | NCT02198365 | Cervical Intrae... | 20 Years - 80 Years | Cathay General Hospital | ||
| An Innovative Treatment for Cervical Precancer (UH3) | NCT03084081 | Cervical Intrae... | CO2 standard th... CryoPen Thermocoagulato... | 18 Years - 65 Years | The Cleveland Clinic | |
| An Innovative Treatment for Cervical Pre Cancer | NCT02814448 | Cervical Intrae... | CryoPen CO2 standard cr... Thermocoagulato... | 25 Years - 65 Years | The Cleveland Clinic | |
| Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation | NCT02411019 | Cervical Intrae... | GX-188E | 19 Years - 50 Years | Genexine, Inc. | |
| Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia | NCT03218436 | Cervical Intrae... | CAP treatment | 18 Years - | University Women's Hospital Tübingen | |
| The Organ Transplant Recipient HPV and Skin Cancer Study | NCT05284877 | Solid Organ Tra... Skin Cancer Skin Dysplasia HPV Infection Cervical Intrae... Cervical Cancer HPV-Related Mal... | No intervention | 18 Years - | Bispebjerg Hospital | |
| Cervical Morphological Changes on Pregnancy Outcome | NCT03242746 | Pregnancy Outco... | 21 Years - 45 Years | The Second Affiliated Hospital of Chongqing Medical University | ||
| Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study | NCT03629886 | Cervical Intrae... | HPV (Types 16, ... | 26 Years - | GlaxoSmithKline | |
| A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age | NCT05496231 | Cervical Intrae... | HPV9 High formu... HPV9 Medium for... HPV9 Low formul... Gardasil 9 | 16 Years - 26 Years | GlaxoSmithKline | |
| A Trial for Patients With Advanced/Recurrent Cervical Cancer | NCT00190983 | Cervical Intrae... Uterine Neoplas... Genital Neoplas... | Pemetrexed | - | Eli Lilly and Company | |
| A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia | NCT00154089 | Cervical Intrae... | EM-1421 | 18 Years - | Erimos Pharmaceuticals | |
| Imiquimod Treatment of CIN Lesions | NCT02329171 | Cervical Intrae... | Imiquimod LLETZ | 18 Years - | Maastricht University Medical Center | |
| A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia | NCT00154089 | Cervical Intrae... | EM-1421 | 18 Years - | Erimos Pharmaceuticals | |
| A Study of ABI-2280 Vaginal Tablet in Participants With Cervical Intraepithelial Neoplasia | NCT05502367 | Cervical Intrae... | ABI-2280 | 25 Years - 55 Years | Antiva Biosciences | |
| Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device | NCT00503919 | Cervical Neopla... | Multi-spectral ... | 18 Years - | M.D. Anderson Cancer Center | |
| Reflectance Confocal Imaging in Cervical Cancer Patients | NCT00505726 | Cervical Cancer | Reflectance Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women | NCT02005510 | Cervical Cancer | Mailed in-home ... Usual care | 30 Years - 64 Years | University of Washington | |
| Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation | NCT02411019 | Cervical Intrae... | GX-188E | 19 Years - 50 Years | Genexine, Inc. | |
| Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls | NCT06243666 | Cervical Intrae... Cervical Cancer Persistent Infe... | Recombinant Hum... No intervention Recombinant Hum... | 18 Years - | Xiamen University | |
| Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod. | NCT03206138 | Cervical Intrae... | GX-188E, GX-I7 GX-188E, Imiqui... | 19 Years - 50 Years | Seoul St. Mary's Hospital | |
| Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study | NCT03629886 | Cervical Intrae... | HPV (Types 16, ... | 26 Years - | GlaxoSmithKline | |
| Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial | NCT02330471 | Uterine Cervica... | Spray Forced | 18 Years - 80 Years | Ruhr University of Bochum | |
| Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) | NCT04537156 | Cervical Intrae... Cervical Cancer Condylomata Acu... | Nonavalent HPV ... Bivalent HPV va... | 18 Years - 45 Years | Xiamen University | |
| Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia | NCT02328872 | Cancer of the C... Cervical Intrae... | Molecular testi... Liquid Based Cy... | 25 Years - 69 Years | VCS Foundation | |
| Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection | NCT03239223 | HSIL HSIL of Cervix High-Grade Squa... High-grade Cerv... Human Papilloma... Cervical Cancer Cervical Intrae... Cervical Neopla... Cervical Dyspla... CIN | ABI-1968 | 25 Years - 50 Years | Antiva Biosciences | |
| Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia | NCT00493545 | Cervical Intrae... | HspE7 and Poly-... | 18 Years - | Nventa Biopharmaceuticals Corporation | |
| CASUS: Validation for Detection of Precursor Lesions | NCT04530201 | Cervical Cancer Cervical Intrae... Human Papilloma... HPV-Related Cer... Urine | Colli-Pee Small... | 25 Years - 64 Years | Universiteit Antwerpen | |
| A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening | NCT01058148 | Cervical Intrae... Human Papilloma... | 26 Years - 65 Years | National Institutes of Health Clinical Center (CC) | ||
| The Dynamic Process of VMB and Mucosal Immunity After FUS Treatment of CIN Patients With Fertility Requirement | NCT05142397 | Cervical Intrae... | Focused Ultraso... | 18 Years - 60 Years | The Second Affiliated Hospital of Chongqing Medical University | |
| A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection | NCT01022346 | Cervical Intrae... | Placebo RO5217790 | 18 Years - | Hoffmann-La Roche | |
| Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device | NCT03429582 | Cervical Intrae... | Standard C02 Cr... Single Tip Ther... Multiple Tip Th... | 18 Years - | The Cleveland Clinic | |
| Investigation of the Uterine Cervix Using CervicalMD | NCT00839475 | Colposcopy | 18 Years - 65 Years | STI-Medical Systems | ||
| DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening | NCT05290428 | Cervical Cancer Cervical Intrae... DNA Methylation Cancer Screenin... Detection Accur... | DNA methylation... | 18 Years - | Peking Union Medical College Hospital | |
| DNA Methylation Biomarkers for Cervical Cancer Screening | NCT02605941 | Cervical Intrae... Cervical Cancer | 20 Years - | iStat Biomedical CO., Ltd. | ||
| Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) | NCT04704908 | Cervical Intrae... Cervical Cancer Vaginal Intraep... Vulvar Intraepi... Persistent Infe... | Recombinant Hum... | 14 Years - 32 Years | Xiamen University | |
| Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9 | NCT03848039 | Cervical Intrae... | Gardasil-9 Placebo | 18 Years - | Azienda USL Toscana Nord Ovest | |
| Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs) | NCT02554344 | Cervical Intrae... | Curcumin | 21 Years - | Baylor Research Institute | |
| Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL | NCT02576561 | Human Papilloma... High-Grade Squa... | TVGV-1 GPI-0100 Placebo | 18 Years - 55 Years | THEVAX Genetics Vaccine | |
| Quality of Life in Thai Women Diagnosed Cervical Cancer at King Chulalongkorn Memorial Hospital | NCT00741533 | Quality of Life Cervical Cancer Cervical Intrae... | 15 Years - 85 Years | Chulalongkorn University | ||
| Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta | NCT00443313 | Cervical Intrae... | 26 Years - 65 Years | National Institutes of Health Clinical Center (CC) | ||
| Management of Cervical Intraepithelial Neoplasia Grade 2 | NCT00733109 | Cervical Intrae... | Excision of the... Follow-up for s... | 18 Years - 61 Years | Universidade Cidade de Sao Paulo | |
| Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3 | NCT01634503 | Cervical Intrae... | GX-188E adminis... | 20 Years - 50 Years | Genexine, Inc. | |
| The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) | NCT02629510 | Cervical Intrae... Cervical Cancer | Tachosil | 20 Years - | Asan Medical Center | |
| Evaluation of Human Papilloma Virus (HPV) Self-testing to Increase Screening Uptake | NCT02095561 | Cervical Intrae... | HPV self testin... | 30 Years - | Instituto Nacional del Cáncer, Argentina | |
| Recurrence in High-grade Lesions After Conization | NCT02540421 | Cervical Intrae... | 18 Years - | Faculdade de Medicina do ABC | ||
| Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions | NCT03226470 | Human Papilloma... | T512 | 18 Years - 50 Years | Huazhong University of Science and Technology | |
| Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma | NCT06191133 | Cervical Intrae... Invasive Cervic... | Fenofibrate Cervical Coniza... Hysterectomy Chemoradiation | 18 Years - | Case Comprehensive Cancer Center | |
| TMTP1-ICG Mapping in Colposcopy-directed Biopsy | NCT03321461 | Cervical Intrae... | TMTP1 ICG | 18 Years - 60 Years | Huazhong University of Science and Technology | |
| Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3) | NCT02195089 | Cervical Intrae... | BLS_ILS_E710c 5... BLS_ILB_710c 10... BLS_ILS_E710c 1... | 20 Years - 50 Years | BioLeaders Corporation | |
| Sexually Transmitted Infections Among African American Women Who Have Sex With Women | NCT01043081 | Sexually Transm... HIV Infections | 18 Years - | University of Mississippi Medical Center | ||
| Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia | NCT04712851 | Cervical Intrae... Cervical Squamo... Cervical Squamo... | Pembrolizumab | 21 Years - | Jonsson Comprehensive Cancer Center | |
| HRME: Screening for Cervical Cancer and Its Precursors in Low-Resource Settings | NCT02494310 | Neoplasia of th... Cancer Preventi... Cervical Intrae... | High-Resolution... | 18 Years - | Barretos Cancer Hospital | |
| Impact of HPV Vaccine On The Prevalence Of HPV In Norway | NCT02934724 | Cervical Intrae... Cervical Cancer Oropharyngeal C... | Self sample fro... Self sample fro... Questionnaire | 18 Years - 20 Years | Oslo University Hospital | |
| Imiquimod Treatment of High-grade CIN | NCT02917746 | Cervical Intrae... | Imiquimod Large Loop Exci... | 18 Years - 99 Years | Maastricht University Medical Center | |
| Cervical Morphological Changes on Pregnancy Outcome | NCT03242746 | Pregnancy Outco... | 21 Years - 45 Years | The Second Affiliated Hospital of Chongqing Medical University | ||
| Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial | NCT05996783 | Cervix Cancer Cervical Intrae... Human Papilloma... HPV-Related Cer... | Colli-Pee Small... Evalyn Brush | 31 Years - 64 Years | Universiteit Antwerpen | |
| A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical Conization | NCT03745846 | Cervical Intrae... HPV | Composite Gel C... placebo | 20 Years - 55 Years | Tianjin Medical University Cancer Institute and Hospital | |
| A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study | NCT03355820 | Cervical Intrae... | Blood sampling ... | 17 Years - | GlaxoSmithKline | |
| Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls | NCT06243666 | Cervical Intrae... Cervical Cancer Persistent Infe... | Recombinant Hum... No intervention Recombinant Hum... | 18 Years - | Xiamen University | |
| Impact of HPV Vaccine On The Prevalence Of HPV In Norway | NCT02934724 | Cervical Intrae... Cervical Cancer Oropharyngeal C... | Self sample fro... Self sample fro... Questionnaire | 18 Years - 20 Years | Oslo University Hospital | |
| Retrospective Study on the Evolution of CIN 1 to 3 in Per and Postpartum in Nancy From 2014 to 2022 | NCT05595252 | Cervical Intrae... | cervical biopsy | - | Central Hospital, Nancy, France | |
| How to Avoid Cervical Stenosis After LEEP in High Grade Cervical Dysplasia? | NCT02500966 | Stenosis Cervix | DUDA device LEEP | 18 Years - 65 Years | Barretos Cancer Hospital | |
| Spectroscopy Versus Standard Care in Cervical Cancer Patients | NCT00529464 | Cervical Cancer | Fluorescence Sp... Colposcopy LEEP Procedure | 18 Years - | M.D. Anderson Cancer Center | |
| Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia | NCT02139267 | Cervical Intrae... | GX-188E | 19 Years - 50 Years | Genexine, Inc. | |
| The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru | NCT01338051 | Cervical Intrae... Cervical Cancer Cervical Neopla... Cervical Dyspla... Human Papilloma... | Gardasil | 30 Years - 45 Years | Preventive Oncology International, Inc. | |
| HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix | NCT04333212 | Cervical Intrae... Human Papilloma... HPV Infection | DR. Chip HPV ge... | 21 Years - 65 Years | Chang Gung Memorial Hospital | |
| Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia | NCT00511615 | Cervical Cancer | Loop Electrosur... | 18 Years - | M.D. Anderson Cancer Center | |
| A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects | NCT03438006 | Cervical Intrae... | Safety data col... | 9 Years - 45 Years | GlaxoSmithKline | |
| Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3) | NCT02195089 | Cervical Intrae... | BLS_ILS_E710c 5... BLS_ILB_710c 10... BLS_ILS_E710c 1... | 20 Years - 50 Years | BioLeaders Corporation | |
| Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine | NCT01356823 | Cervical Intrae... Cervical Cancer | 30μg HPV 60μg HPV 90μg HPV Hepatitis B vac... | 18 Years - 25 Years | Xiamen University | |
| Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device | NCT00503919 | Cervical Neopla... | Multi-spectral ... | 18 Years - | M.D. Anderson Cancer Center | |
| Randomized Controlled Trial to Study Interventions to Increase Participation in Cervical Cancer Screening Program | NCT01029990 | Cervical Intrae... | Telephone arm Self-test arm | 29 Years - 63 Years | Göteborg University | |
| HPV-cytology Testing Versus Cytology Testing for the Detection of High Grade CIN | NCT01058460 | Cervical Cancer Cervical Intrae... | HPV-cytology co... | 30 Years - 60 Years | The University of Hong Kong | |
| A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects | NCT03438006 | Cervical Intrae... | Safety data col... | 9 Years - 45 Years | GlaxoSmithKline |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
